Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1006534]Researchers: Prof Paul Gorry (Principal investigator) , Prof Melissa Churchill , Prof Sharon Lewin
Brief description CCR5 antagonists are a new type of anti-HIV-1 drug that stops the virus from entering cells. We have evidence to suggest that the ability of CCR5 antagonists to function properly is linked to the ability of HIV-1 to infect a type of immune cell called macrophages. In this proposal, we will investigate precisely how HIV-1 enters macrophage cells, and then determine how this may influence the outcome of patients who are receiving these drugs as part of their clinical care.
Funding Amount $AUD 635,506.67
Funding Scheme NHMRC Project Grants
Notes Standard Project Grant
- nhmrc : 1006534
- PURL : https://purl.org/au-research/grants/nhmrc/1006534
